Originally published In Press as doi:10.1074/jbc.M201034200 on March 29, 2002
J. Biol. Chem., Vol. 277, Issue 23, 20195-20204, June 7, 2002
The 25-kDa Synaptosome-associated Protein (SNAP-25) Binds and
Inhibits Delayed Rectifier Potassium Channels in Secretory Cells*
Junzhi
Ji
§,
Sharon
Tsuk§¶,
Anne Marie F.
Salapatek§
,
Xiaohang
Huang§**,
Dodo
Chikvashvili¶,
Ewa
A.
Pasyk
,
Youhou
Kang
,
Laura
Sheu
,
Robert
Tsushima
,
Nicholas
Diamant
,
William S.
Trimble
§§,
Ilana
Lotan¶, and
Herbert Y.
Gaisano
¶¶
From the Departments of
Medicine,
Physiology,
and 
Biochemistry, University of Toronto,
Toronto, Ontario M5S 1A8, Canada, the §§ Program in Cell
Biology of the Hospital for Sick Children, Toronto, Ontario M5G 1X8,
Canada, ** First Institute of Oceanography, State Ocean
Administration, Qingdao 266061, China, and ¶ Department of
Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv
University, Tel-Aviv, Israel 69978
Received for publication, January 31, 2002, and in revised form, March 28, 2002
 |
ABSTRACT |
Delayed-rectifier K+ channels
(KDR) are important regulators of membrane excitability in
neurons and neuroendocrine cells. Opening of these
voltage-dependent K+ channels results in
membrane repolarization, leading to the closure of the Ca2+
channels and cessation of insulin secretion in neuroendocrine islet
cells. Using patch clamp techniques, we have demonstrated that the
activity of the KDR channel subtype, KV1.1,
identified by its specific blocker dendrodotoxin-K, is inhibited by
SNAP-25 in insulinoma HIT-T15
cells. A co-precipitation study of
rat brain confirmed that SNAP-25 interacts with the KV1.1
protein. Cleavage of SNAP-25 by expression of botulinum neurotoxin A in HIT-T15 cells relieved this SNAP-25-mediated inhibition of
KDR. This inhibitory effect of SNAP-25 is mediated by the N
terminus of KV1.1, likely by direct interactions with
KV
1.1 and/or KV
subunits, as revealed by
co-immunoprecipitation performed in the Xenopus oocyte
expression system and in vitro binding. Taken together we
have concluded that SNAP-25 mediates secretion not only through its
participation in the exocytotic SNARE complex but also by regulating
membrane potential and calcium entry through its interaction with
KDR channels.
 |
INTRODUCTION |
In islet
cells, glucose-mediated Ca2+-evoked
insulin secretion is initiated by the closure of ATP-sensitive
K+ channels, which in turn causes membrane depolarization
and the resultant opening of L-type Ca2+ channels (1). The
cessation of insulin secretion is brought about by the closure of these
Ca2+ channels by membrane repolarization, which is
primarily effected by the opening of a voltage-dependent
K+ channels
(KV)1 of the
delayed rectifier subtype (KDR) (2). Regulation of KDR activity therefore directly affects the duration and
extent of Ca2+ channel opening-ensuing Ca2+
influx. In neurons, the short duration of action potentials regulates rapidly activating and inactivating N-type Ca2+ channels,
resulting in ultrashort (µs) Ca2+ fluxes acting on docked
synaptic vesicles (3). In contrast to neurons that have a higher
proportion of readily releasable docked vesicles (~10%), less than
5% of insulin-containing secretory granules in islet
cells are
morphologically docked, with the vast majority of insulin granules
located more distantly from the membrane within a reserve pool (4). A
more sustained Ca2+ influx effected by a much longer train
of action potentials would be necessary to reach and mobilize this
reserve pool of insulin granules to the plasma membrane and then to
effect their exocytosis (3, 4). This contributes to the more sustained
phase of secretion, also observed in other neuroendocrine cells (5). In
the islet
cell, since this glucose-sensitive sustained phase of
insulin secretion is regulated by the KDR channel, it would be an ideal drug target for the treatment of
non-insulin-dependent or type 2 diabetes. In particular,
drugs that interfere selectively with it would be superior to the
current treatment with sulfonylureas that act on
cell
KATP channels in a glucose-independent manner, often
resulting in deleterious side effects such as hypoglycemia (6).
However, very little is known about the KDR channel or the
identities of the molecules interacting with this channel (2).
The target-SNAREs, SNAP-25 and syntaxin, and the
vesicleSNARE, vesicle-associated membrane protein, are
thought to comprise the minimal machinery required for membrane fusion
and exocytosis (7, 8). These proteins all possess
-helical domains
that interact to form a stable coiled-coil complex, the formation of which likely drives membrane fusion (7, 8). Clostridial neurotoxins,
which specifically cleave these SNARE proteins, have been valuable
tools in revealing SNARE protein functions (9
11). t-SNARE proteins
syntaxin 1A and SNAP-25 can also directly interact with membrane ion
channels involved in regulating the secretory process. Syntaxin 1A and
SNAP-25 bind to (12, 13) and modulate neuronal (12-14) and
neuroendocrine (pancreatic islet
cells) (15, 16) Ca2+
channels. More recently, syntaxin has also been shown to modulate epithelial Na+ (17, 18), Cl
(19, 20), and
voltage-gated K+ (21) channels.
In this study, we have begun to explore the molecular interactions
between KDR channels and the critical t-SNARE, SNAP-25. Here we show that SNAP-25 interacts with insulinoma HIT-T15 cell KDR, specifically via the Kv
1.1 subunit.
Overexpression of SNAP-25 or exogenously applied recombinant SNAP-25
protein inhibits HIT cell KDR activity. Cleavage of SNAP-25
by botulinum neurotoxin A (BoNT/A) light chain expression relieves the
actions of endogenous and exogenous SNAP-25 on KDR.
Furthermore, the N-terminal domain but not C-terminal domain of
KV1.1 competitively reversed the effect of SNAP-25. This
work demonstrates that SNAP-25 modulates secretion not only by its
involvement in membrane fusion but also by its interaction with
KDR channels.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture, Transfection, and Plasma Membrane Fractionation
HIT-T15 cells (a gift from P. Robertson, Seattle, WA) were
cultured at 37 °C in 5% CO2, 95% air in RPMI 1640 medium supplemented with 20 mM glutamine, 10% fetal calf
serum (Invitrogen), penicillin (100 units/ml), and streptomycin (100 mg/ml). These cells were then transfected with plasmids (pcDNA3)
containing cDNAs of full-length SNAP-25 or BoNT/A light chain (a
gift from H. Niemann, Hanover, Germany) exactly as we report (22).
48 h later, we noted the transfection efficiency to be ~30-40%
as determined by visualization of the co-expressed green fluorescent
protein (GFP) (CLONTECH, Palo Alto, CA), which was
also used to identify the transfected cells for the
electrophysiological studies. To determine the levels of Kv1.1 and
SNARE proteins, these transfected HIT cells were further subjected to
subcellular fractionation (i.e. whole-cell lysate and plasma
membrane). The HIT-T15 cells were dislodged from the plates with
trypsin and then washed twice with phosphate-buffered saline after
alternate centrifugation (2000 rpm, 5 min). The resulting pellet was
resuspended in a homogenization buffer (in mM: 150 NaCl, 20 Tris-HCl, 1 EDTA, 1 EGTA, and protein inhibitors) and homogenized using
a sonicator. Large debris and nuclear fragments were removed by low
centrifugation (2000 rpm for 5 min, IEC-8R centrifuge) at 4 °C, and
the resulting pellet was resuspended and subjected to
ultracentrifugation (50,000 rpm for 1 h, TL-100 ultracentrifuge).
The pellet was then suspended in SDS-loading buffer and centrifuged at
2000 rpm at 4 °C for 5 min, and the supernatant containing the
purified plasma membrane fraction was collected. Protein concentrations
of the whole-cell lysate and plasma membrane fractions were determined
by a modified Lowry method. About 15 µg of protein from cell lysate
and 70 µg of protein from membrane preparation were separated on an 8 or 14% SDS-PAGE and transferred to a nitrocellulose membrane, and the
blots were then identified with specific primary antibodies against
SNAP-25 (1:1000) (22) or KV1.1 (1:200, Alomone Labs,
Jerusalem, Israel).
Immunoprecipitation
Rat Brain Homogenates--
Rat brain synaptosomal heavy membrane
LP1 fraction was prepared exactly as described by Huttner et
al. (23). LP1 protein (350-600 µg) was incubated in
lysis buffer (150 mM NaCl, 50 mM Tris, pH 7.5, 0.1% Triton X-100 containing a mixture of protease inhibitors) to a
concentration of >1 mg/ml in ice for 10 min, and then 1 µg of
affinity-purified antibody (SNAP-25) was added. This mixture was then
agitated overnight at 4 °C followed by the addition of 50-100 µl
of 50% slurry of protein G-Sepharose and further agitated for 4 h. The Sepharose beads were then spun-down, washed 4 times with
ice-cold lysis buffer, solubilized in sample buffer, and heated at
80 °C for 3 min. The proteins within the immunoprecipitated
complexes were then separated on SDS-PAGE and identified by specific
primary antibodies anti-SNAP-25 (1:1000) (22) and
anti-KV1.1 (1:1000, Alomone Labs).
Xenopus laevis Oocytes--
Oocytes were prepared as described
(24), injected (50 nl/oocyte) with the mRNAs, metabolically labeled
for 3 days, and subjected to immunoprecipitation, as described (25).
Immunoprecipitates from 1% Triton X-100 homogenates of whole oocytes
were analyzed by SDS
PAGE. Digitized scans were derived by
PhosphorImager (Molecular Dynamics/Sunnyvale, CA or Invitrogen). Here,
the primary antibodies used were polyclonal anti-KV1.1 and
anti-SNAP-25 (Alomone Labs), Kv1.1, and
Kv
1.1 (a gift from O. Pong, Hamburg, Germany) cDNAs;
their mRNA preparations have been previously described (26).
Binding of Glutathione S-Transferase (GST) Fusion Proteins
The fusion proteins were synthesized as previously described
(27, 28). The protein concentration was estimated using the Bio-Rad
protein assay kit. Purified GST fusion proteins (200 pmol) or purified
GST (200 pmol) immobilized on glutathione-Sepharose beads (Amersham
Biosciences; 40 µl of beads were added, incubated for 30 min at
4 °C, and washed 3 times in 1 ml of phosphate-buffered saline with
0.1% Triton X-100) were incubated with 5 µl of the lysate containing
35S-labeled SNAP-25 (translated on the template of in
vitro synthesized RNAs using a translation rabbit reticulocyte
lysate kit (Promega) according to the manufacturer's instructions) in
1000 µl of phosphate-buffered saline with 0.1% Triton X-100 for
1 h at room temperature with gentle rocking. After washing, the
GST fusion proteins were eluted with 15 mM reduced
glutathione in 40 µl of elution buffer (120 mM NaCl, 100 mM Tris-HCl, pH 8.0) and analyzed by 12% SDS-PAGE. DNAs of
Kv1.1 and Kv
1.1 fragments to create GST
fusion proteins have been previously described (27).
Electrophysiology
Previously transfected GFP-positive HIT cells (passage 65-75)
were studied with standard whole-cell and cell-attached patch clamp
techniques (29) as we have previously described (30). The standard
pipette solution contained the following (in mM) except
where noted in the text: 140 KCl, 1 MgCl2, 10 HEPES, 4 Na2ATP, 0.3 EGTA, and 8 nM CaCl2,
pH 7.2. The external solution contained (in mM): 140 NaCl,
4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, pH 7.4. Axopatch 1D and 200B patch clamp amplifiers were used together with
pCLAMP software (v.6.0, Axon Instruments, Union City, CA) to
record channel currents. Currents were typically elicited from a
holding potential of
70 mV. Data were presented as mean ± S.E.
and compared by Student's t test for single comparisons and
by analysis of variance for multiple comparisons. p < 0.05 was considered to be statistically significant. Single-channel recording and analyses were performed in the cell-attached
configuration in which HIT-T15 cells were bathed in the internal
solution (high K+) and pipettes contained a normal external
solution. Test pulses of 30s from
70 to
10 mV were applied every 3 min. Analog signals were filtered at 2 kHz using a Bessel filter.
Single channel data were analyzed using Fetchan and pSTAT software
(pCLAMP 6.0, Axon Instruments). Recombinant proteins including
GST-SNAP-25, GST
T1A, GST
T1B,
GST-KV1.11-168, and
GST-KV1.1411-495 were generated as previously
described (27, 28) and dialyzed into a cell via the patch pipette. A
single voltage step to +30 mV from a holding potential of
70 mV was
used to assess the effects of these test proteins on
KDR.
 |
RESULTS |
Insulinoma HIT Cell KDR Is Similar to That of Islet
Cells--
To determine whether the KDR in HIT-T15 (HIT)
cells are similar to those reported in islet
cells (2, 31, 32), we functionally and molecularly characterized this channel protein. Like
islet
cell KDR (2, 32), HIT cell KDR
possesses several similar functional properties (Fig.
1A). These properties include K+ ion selectivity, as demonstrated by an inhibitory effect
of Cs+ ion, when intracellular KCl was replaced with CsCl
(Fig. 1A, CsCl), a low threshold of activation
(
30 mV), and slow inactivation (>250 ms, shown in Fig.
1A, inset, and graphic summary). Characteristic of KDR, the HIT cell KDR was inhibited by high
doses of the semi-selective K+ channel blocker
tetraethylammonium (20 mM TEA in Fig. 1A,
inset), which caused ~85% reduction (p < 0.05) in the outward current at +30 mV (31). Because large conductance
Ca2+-sensitve K+ currents (KCa)
also contributes to the outward currents in islet
cells (32), we
determined the contribution of this channel to total outward currents.
Like others (31), we also found that KCa contributed little
to the HIT cell outward currents, as evidenced by (a)
insensitivity to low intracellular Ca2+ concentrations
(with 8 nM Ca2+, <8% reduction in outward
currents, data not shown) or the Ca2+ channel blocker
nifedipine (Fig. 1A), (b) insensitivity to low doses of TEA (<10% reduction at 1 mM TEA, not shown), or
(c) inhibition by 100 nM iberiotoxin, a specific
large conductance KCa blocker (Fig. 1A,
iberiotoxin (IbTX)). Nonetheless, to negate even this small
contribution of KCa to the outward currents, all pipette solutions contained low Ca2+ concentration (<8
nM).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
HIT-T15 cell KDR
identification. Typical whole-cell KDR currents evoked
with one-step voltage depolarization to +30 mV in a control cell before
( ) and after it is inhibited by TEA (20 mM) application
to the extracellular solution ( ) (A, inset).
A, effects of various K+ channel blockers:
iberiotoxin (IbTX; 10 7 M, ,
n = 6), TEA (20 mM, , n = 6), CsCl (replaced KCl in the pipette solution, 140 mM,
, n = 5), and a Ca2+ channel blocker,
nifedipine (NIF; 10 5 M, ,
n = 6) on the mean steady-state current-voltage
relationship recorded from control HIT cells ( , n = 12). Whole-cell currents were evoked in response to a series of test
pulses between 50 and +50 mV in 20-mV steps from a holding potential
of -70 mV. KDR currents were remarkably reduced by TEA and
CsCl. B, representative families of whole-cell
KDR currents recorded from a control and a SNAP-25- and a
BoNT/A-transfected cell. Currents were evoked in response to a series
of test pulses from -50 to +50 mV in 10-mV steps from a holding
potential of -70 mV. Steady-state current-voltage curves were obtained
from control ( , n = 16), SNAP-25- ( ,
n = 18) or BoNT/A-transfected cells ( ,
n = 14) (B, right panel). Data
are presented as the mean ± S.E. The asterisk
indicates p < 0.05 against control by analysis of
variance. C, effects of DTX-K, a specific KV1.1
blocker, on KDR currents. Representative outward currents
recorded from a control and a SNAP-25- and a BoNT/A-transfected cell
before ( , basal) and after 300 nM DTX-K addition ( ).
Current traces were caused by one-step depolarization to +30 mV from a
holding potential of -70 mV (C, left 3 panels).
The bar graph shows the effects of DTX-K on the steady-state
KDR currents (mean ± S.E.) in the control
(n = 6) and SNAP-25- (n = 6) or
BoNT/A-transfected cells (n = 6) (C,
right panel). The asterisk indicates
p < 0.05 versus basal. KDR
current levels after the DTX-K addition in control or SNAP-25- or
BoNT/A- overexpressing cells (see graph) were very close. The
dotted lines are the zero current level. Currents are
normalized to cell membrane capacitance.
|
|
SNAP-25 Inhibits Whole-cell KDR Subtype,
KV1.1 Currents--
We and others previously showed that
in pancreatic islets and insulinoma cell lines including HIT cells,
SNAP-25 expression is required for insulin secretion (22, 33, 34).
Furthermore, t-SNARE proteins syntaxin 1A and SNAP-25 can also directly
interact with membrane ion channels involved in regulating the
secretory process (15, 16). To determine whether SNAP-25 can modulate KDR channels, we overexpressed SNAP-25 in HIT cells (Figs.
1B, 2B, and 3B). We already reported
that overexpressed SNAP-25 proteins are appropriately targeted to the
plasma membrane (22), which would allow for their interaction with
membrane-spanning ion channel proteins such as KV1.1.
SNAP-25- or BoNT/A-transfected cells were identified by their
expression of co-transfected GFP (22). All control cell studies were
performed on cells transfected with GFP alone, and neither
KDR activity (data not shown) nor insulin secretion was
altered by GFP transfection (22).
Fig. 1B shows representative whole-cell KDR
current traces after transfection and a graphical summary of the peak
currents, which have been normalized by cell membrane capacitance for
minimizing variations in cell size. Transfection of HIT cells with
SNAP-25 resulted in a 3-fold increase in SNAP-25 expression in total
HIT lysates (Fig. 2A,
lane 3). Transfection efficiency as determined by the
frequency of GFP-positive cells is consistently ~40%. With this
transfection efficiency of ~40%, the transfected cells studied by
patch clamp would be estimated to contain about a 5-6-fold increase in
SNAP-25 compared with endogenous levels. In cells overexpressing
SNAP-25, the peak KDR current (86.9 ± 6.2 pA/picofarads, n = 18, p < 0.05) was inhibited at +30 mV by 22% compared with control cells
(111.3 ± 7.9 pA/picofarads, n = 16) (Fig.
1B). We reasoned that if SNAP-25 genuinely acts to inhibit
KDR, then BoNT/A cleavage of SNAP-25 should enhance
KDR currents. We therefore overexpressed BoNT/A light chain
in HIT cells. BoNT/A expression reduced endogenous SNAP-25 levels of
HIT lysates to ~10% of control levels (Fig. 2A,
lane 4). Therefore, in cells expressing BoNT/A, it can be
assumed that all endogenous SNAP-25 would be cleaved (22).
KDR currents in these BoNT/A-expressing cells were
augmented at +30 mV by 22% (135.4 ± 8.9 pA/picofarads,
n = 14, p < 0.05) compared with
control cells (Fig. 1B). Indeed, these effects of BoNT/A are
opposite to the effects of SNAP-25 overexpression, which would
therefore suggest that BoNT/A cleavage of SNAP-25 removes the
inhibitory actions of full-length SNAP-25. BoNT/A cleavage of SNAP-25
also revealed a smaller band (Fig. 2A, lower unfilled
arrowhead of the arrowhead doublets to the
right of lanes 4 and 7), which is
likely the SNAP-25 cleavage product representing amino acids 1-197
(22, 34).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of SNAP-25 and BoNT/A transfection on
KDR channel expression and channel kinetics.
A, expression of SNAP-25 (lower panel) and the
voltage-activated K+ channel (KV) subtype,
KV1.1 (upper panel) in HIT cells. HIT cells
transfected with an empty vector (Control, lanes 2 and 5), SNAP-25 (lanes 3 and 6)
or BoNT/A (lanes 4 and 7) were lysed by
sonication or subjected to subcellular fractionation to obtain a
purified plasma membrane fraction. Western analysis using specific
antibodies to SNAP-25 (22) and KV1.1 (Alomone Labs) was
performed on these HIT cell lysates (15 µg, lanes
2-4) and plasma membrane fractions (70 µg,
lanes 5-7). Rat brain synaptosomal membrane
fraction (LP1, 10 µg of protein) was used as the positive control. In
BoNT/A-transfected HIT cells, we observed a slightly smaller (by ~1
kDa, indicated by lower open arrowhead on
lanes 4 and 7) SNAP-25 immunoreactive band, which
is likely the larger SNAP-25 cleavage product (amino acids 1-197).
B (top left), representative whole-cell
KDR activation current traces were evoked by depolarization
to +10 mV for 300 ms from a holding potential of -70 mV and normalized
to the same amplitude to compare their activation time course. Time
constants of activation were obtained by fitting each current trace
with a monoexponential equation over test voltages from +10 to +40 mV
(B, bottom left). Each point was expressed as the
mean ± S.E. The asterisk indicates p < 0.05 against control. SNAP-25 ( , n = 8)
decelerated KDR activation, whereas SNAP-25 cleavage by
BoNT/A expression ( , n = 8) accelerated
KDR activation when compared with control cells ( ,
n = 12). B (top right),
representative whole-cell KDR inactivation current traces
were evoked by a 10-s pulse to +10 mV from a holding potential of -70
mV, and these traces were normalized to the same amplitude to compare
their decay. Time constants of inactivation were fitted by a
biexponential equation to calculate fast (not shown) and slow time
constants, represented by the histogram (B, bottom
right). Data were the mean ± S.E. from control
(n = 8), SNAP-25 (n = 6), and
BoNT/A-transfected cells (n = 6), respectively. The
asterisk indicates p < 0.05 against
control. SNAP-25 accelerated KDR inactivation, whereas
SNAP-25 cleavage by BoNT/A expression decelerated KDR
inactivation when compared with control cell KDR
inactivation.
|
|
To identify the KDR subtype upon which SNAP-25 acted, we
first applied dendrotoxin (DTX), which blocks
Kv1.1 and Kv1.2 channels, and subsequently
applied dendrotoxin-K (DTX-K), which more specifically blocks only
Kv1.1 channels. We found that both toxins exhibited identical effects, and therefore, we show only the more specific DTX-K
results in Fig. 1C. DTX-K (300 nM) application
had no significant additional effects in SNAP-25-expressing cells
compared with controls in which there was a 33% drop in
KDR current (p < 0.05). Thus, the
KDR subtype upon which SNAP-25 acted was Kv1.1.
We confirmed the presence of the KV1.1 channel protein in
HIT cell lysates as shown in Fig. 2A in lane 2 (HIT Cell lysate, Control). This KV1.1 antibody (Alomone Labs) has been depleted of
antibodies that reacted with closely related KV isoforms.
KV1.1 was previously identified in HIT cells (35) and also
in human islets and human insulinoma
cells (2). Furthermore,
HIT-T15 does not express the closely related KV1.2 channel
protein, as confirmed by us at the protein (by anti-KV1.2
antibody, Alomone Labs) and mRNA (by reverse transcription-PCR)
levels (36).
Because the KDR current in HIT cells is likely to be
contributed by KV channels other than KV1.1
(36), we next examined whether the SNAP-25-sensitive component of the
KDR current is predominantly KV1.1. In Fig.
1C, we expressed BoNT/A to cleave endogenous SNAP-25, which
predictably increased the KDR currents (representative
trace on the left, and summary on the right) over controls as was shown in Fig. 1B. More importantly, the
application of DTX-K (300 nM) inhibited the KDR
current of the BoNT/A-transfected HIT cells to precisely the same
extent as the control and SNAP-25-overexpressing cells (Fig.
1C), indicating that the SNAP-25-sensitive KDR
current in the HIT cells is indeed from KV1.1 channels.
SNAP-25 Decelerates Activation and Accelerates Inactivation of
Whole-cell KDR Currents--
There are two possible
explanations for the differences in whole-cell KDR current
magnitude observed in Fig. 1B. First, SNAP-25 or BoNT/A
expression could affect KDR synthesis and cell surface expression. In this way, changes in peak KDR current would
reflect a change in channel density rather than in KDR
activity. Fig. 2A (upper panel) shows that there
is no obvious difference in the levels of KV1.1 protein
(indicated by rat brain positive control, 86 kDa) expression in
whole-cell lysates of HIT cells overexpressing SNAP-25 (lane
3) or BoNT/A (lane 4) when compared with control HIT
cell lysates (lane 2), indicating that there was no gross effects on KV1.1 synthesis. To assess the effects on
KV1.1 expression at the cell surface, which could be due to
changes in endocytotic or exocytotic events, we determined
KV1.1 levels in the plasma membrane fraction (Fig.
2A, upper panel, lanes 5-7). To our
surprise, KV1.1 expression in the plasma membrane
preparation was reduced to 84% of control in the
SNAP-25-overexpressing HIT cells (lane 6, Fig.
2A). This reduction of KV1.1 expression at the
cell surface would therefore at least contribute to the decreased
current density observed in SNAP-25-transfected cells (Fig.
1B). However, if the primary action of SNAP-25 is to
regulate KV1.1 transport to the cell surface, we would
expect an augmented expression of KV1.1 in the plasma
membrane after cleavage of endogenous SNAP-25 by overexpression of
BoNT/A. This was not the case since BoNT/A overexpression, which
reduced the membrane SNAP-25 levels to ~10% of controls, did not
cause an increase in the plasma membrane levels of KV1.1. In fact, the KV1.1 levels in the plasma membrane
(lane 7, Fig. 2A) were reduced to 49% of
control, which we believe may in part be due to nonspecific proteolysis
during the membrane preparation caused by the BoNT/A expression. Of
note, the plasma membrane SNAP-25 levels of the SNAP-25-overexpressing
HIT cells was greater than 5-fold normal levels, which is much greater
in proportion to the reduction of membrane KV1.1 levels,
suggesting a pharmacological effect of the overexpressed SNAP-25. In
the SNAP-25- and BoNT/A-transfected HIT cell lysates and plasma
membrane, syntaxin 1A levels did not change (data not shown).
The most plausible explanation is that endogenous SNAP-25 physiologic
actions are to inhibit KDR channel activity. We tested this
possibility by examining the effects of SNAP-25 on the activation and
inactivation kinetics of the whole-cell KDR current. Fig. 2B demonstrates that the overexpressed SNAP-25 acts to
decelerate KDR activation and accelerate KDR
inactivation, with the time constants for activation and inactivation
at +10 mV of 21.5 ± 1.0 ms (n = 8) and 3.2 ± 0.3 s (n = 6), respectively. These values were
significantly different (p < 0.05) than those for
controls, which had activation and inactivation time constants of
16.3 ± 1.0 ms (n = 12) and 4.3 ± 0.3 s
(n = 8), respectively. In contrast, cleavage of
SNAP-25 by BoNT/A had the opposite effect, resulting in acceleration of
activation and deceleration of inactivation (shown in Fig.
2B), with the time constants for activation and inactivation
of 11.6 ± 0.7 ms (n = 8) and 5.4 ± 0.5 s (n = 6), respectively. These values were also
significantly different (p < 0.05) than those for
controls (as above). These differences in time-dependent
kinetics of the KDR channel effected by SNAP-25 and SNAP-25
cleavage by BoNT/A would contribute to the reduction or augmentation,
respectively, of the peak KDR current observed in cells
overexpressing SNAP-25 or BoNT/A (shown in Fig. 1B).
SNAP-25 Inhibits Single KDR Channels--
Single
channel studies on cell-attached patches revealed single K+
channels in HIT cells that possess a unitary conductance of 10 picosiemens, as determined from the slope conductance (Fig.
3A), which is similar to that
reported for KDR in
cells (31). This conductance is
like that reported for the KV1.1 voltage-activated K+ channel isoform expressed in oocytes (37). We next
attempted to determine whether SNAP-25 affected the probability of
channel opening or the conductance of single KDR channels
in cell-attached patches (Fig. 3, B-D). Sample traces are
shown in Fig. 3B. We examined these single KDR
channel currents evoked by a voltage pulse to
10 mV in all
transfected cells. We found that neither SNAP-25 nor BoNT/A
transfection had any effects on KDR channel conductance,
with all single channel slope conductances calculated to be 10 picosiemens. This is reflected by the observation that the mean unitary
channel current amplitude at
10 mV for each of the transfections was
not significantly different from control cells, ranging from 0.47 to
0.51 pA (Fig. 3C). However, SNAP-25 overexpression greatly
reduced the number of KDR channel openings (Fig.
3C), and furthermore, the mean KDR channel open
time (7.6 ± 3.7 ms, n = 5, p < 0.05) shown in Fig. 3D was greatly shortened by 59%
compared with control cells (18.2 ± 2.3 ms, n = 5). In contrast, cleavage of endogenous SNAP-25 by BoNT/A transfection resulted in a profound increase in the number of channel openings (Fig.
3C) and a prolongation in KDR channel open time
by 150% (45.6 ± 3.2 ms, n = 5, p < 0.05 versus control in Fig. 3D). These altered
single channel activities collectively contribute to the observed
changes in the macroscopic, whole-cell currents arising from this
population of KDR channels shown in Figs. 1B and
2B.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
SNAP-25 regulation of single KDR
channels. A (left), single channel
KDR currents were recorded from membrane patches of control
HIT cells in the cell-attached configuration. Currents were evoked in
response to a random series of test pulses between -40 and +20 mV in
20-mV steps from a holding potential of -70 mV. Each test pulse lasted
for 30s, with an interpulse interval greater than 3 min. A
(right), current-voltage relationship obtained from single
channel studies in which a mean single channel conductance of 10 picosiemens was calculated from the slope of line best-fitted to the
data (n = 5). B, five representative single
channel KDR currents recorded from cell-attached patches of
control cells or cells overexpressing SNAP-25 or BoNT/A under the same
experimental conditions described in Fig. 1B. Currents were
evoked from transfected cells during a pulse from a holding potential
of -70 to -10 mV recorded for 330 ms. C, amplitude
histograms for each of these transfections were calculated. SNAP-25
overexpression greatly reduced the number of KDR channel
openings over control cells. Conversely, cleavage of SNAP-25 by BoNT/A
expression enhanced the number of KDR openings over both
control and SNAP-25-transfected cells. KDR channel currents
measured at 10 mV were the same magnitude for all transfections
(ranging from 0.47 to 0.51 pA), suggesting that channel conductance was
not changed. There was no change in KDR channel conductance
with any transfection (data not shown). D, frequency
versus lifetime histogram of channel openings. A total of
greater than 1550 events were analyzed for each of the transfection and
the open time distribution fitted to a single exponential with a time
constant ( ). SNAP-25 (n = 5) shortened the duration
of the KDR open time, whereas cleavage of SNAP-25 by
expressed BoNT/A (n = 5) significantly increased the
mean channel open time when compared with the mean KDR
channel open time recorded from control cells (n = 5)
(p < 0.05 against control cells for all test
cells).
|
|
The Time-dependent Inhibitory Actions of Exogenous
SNAP-25 on KDR Are Relieved by BoNT/A
Proteolysis--
To more clearly distinguish the effects of the
overexpressed SNAP-25 on the cell surface expression of
KV1.1 (in Fig. 2A) and the direct effects of
SNAP-25 on the KV1.1 channel, we examined the effects of
acutely applied exogenous recombinant SNAP-25 protein (introduced via
the patch pipette after membrane rupture) in control (Fig.
4, A-C) and BoNT/A-expressing
cells (Fig. 4C). This strategy also allowed us to examine
the time course of action of SNAP-25 on KDR. Furthermore,
SNAP-25 overexpression in other cell types leads to chronic effects
such as alteration in axonal growth (38) and vesicular trafficking
processes (39). It has been previously shown (40) that for a 10-megaohm
access-resistance pipette, a protein with a molecular mass of 50 kDa
can diffuse into the cytosol with a time constant of 5 min. Because the
diffusion time constant varies with the third root of the molecular
mass of the diffusing substance, we expected that the concentration of
the smaller SNAP-25 (25 kDa) in cytosol would be greater than 72% of
the pipette concentration within 5 min. Therefore, we expected to see
exogenously applied SNAP-25-mediated effects within 5 min, which was
indeed the case.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Acute inhibition of KDR currents
by intracellular dialysis of recombinant GST-SNAP-25.
A, representative current traces show the reduction of
KDR currents with recording time from a control HIT cell
dialyzed with10 9 M GST-SNAP-25.
KDR currents were caused by depolarization to +30 mV from a
holding potential of -70 mV. B, graphical summary of
dose-dependent and time-dependent inhibition of
KDR currents by dialysis of GST-SNAP-25 into HIT cells.
Steady-state KDR current amplitudes were normalized to
corresponding maximal current levels
(I/Imax). Data are expressed as
mean ± S.E. (n = 5-6). The single
asterisk indicates p < 0.05, and the double
asterisk indicates p < 0.01 compared with
10 8 M GST alone. C, inhibitory
effect of exogenous SNAP-25 on KDR is relieved by BoNT/A
proteolysis. KDR currents were recorded over a 30-min time
period with an initial interpulse interval of 12 s followed by a
slower interpulse interval of 3 min after the first 3 min. To directly
compare these effects, KDR currents obtained from
GST-SNAP-25 dialysis in both control and BoNT/A-expressing cells were
normalized as a percentage of the initial effect (immediately after
cell membrane rupture) of inactive GST-alone dialyzed into control
cells. Data are the mean ± S.E. Dialysis of 10 8
M GST into control cells ( , n = 5) had
no effect on KDR. GST-SNAP-25 dialyzed into control cells
( n = 4) resulted in prolonged inhibition of
KDR currents. GST-SNAP-25 dialyzed into BoNT/A-expressing
cells ( , n = 5) resulted in an initial inhibition of
KDR currents, which paralleled that seen in control cells.
This inhibition reversed after the onset of BoNT/A cleavage of
GST-SNAP-25, resulting in the complete removal of the inhibitory effect
of GST-SNAP-25 on KDR currents after 30 min.
|
|
GST-SNAP-25 inhibited KDR currents in a dose- and
time-dependent manner. Fig. 4A shows a
representative series of KDR currents demonstrating a
time-dependent reduction in KDR currents in a control HIT cell dialyzed with 10
9 M
GST-SNAP-25. Fig. 4B is a summary (n = 5-6
cells each) of the dose-dependent inhibition of
KDR by SNAP-25. 10
10 M
GST-SNAP-25 had minimal effects on KDR even 5 min after
membrane rupture when compared with GST (10
8
M) alone, which had no effect (even after up to 30 min, as
shown in Fig. 4C). In contrast, 10
9
M GST-SNAP-25 caused a significant 25% reduction of
KDR currents 4 min after membrane rupture (Fig.
4B). At a higher concentration of GST-SNAP-25
(10
8 M), the inhibition reached a significant
level just 2 min after membrane rupture, with a maximal level of 39%
occurring at 5 min (Fig. 4B). In Fig. 4C, we
recorded for up to 30 min and found that this maximal inhibition of
KDR by 10
8 M GST-SNAP-25 was
maintained. These acute changes on KDR currents by
exogenous application of SNAP-25 precisely mirrored those caused by
SNAP-25 overexpression (Fig. 1B), which supports our
thinking that a dominant action of the excess SNAP-25 is to inhibit
KDR currents.
We next wanted to examine the effects of the active cleavage of SNAP-25
by BoNT/A on KDR activity. To demonstrate this, we dialyzed
GST-SNAP-25 into BoNT/A-expressing HIT cells (Fig. 4C). In vivo expression of BoNT/A light chain ensured continued
cleavage of SNAP-25 from both endogenous synthesis and exogenous
application. The initial KDR current recorded immediately
after membrane rupture in BoNT/A-expressing cells was 23 ± 1%
(n = 5, p < 0.05), higher than that
recorded in control cells (Fig. 4C). The initial higher KDR values in the BoNT/A cells is due to cleavage of
endogenous SNAP-25, which is expected to be the case before dialysis of
exogenous GST-SNAP-25 into the cytosol (Fig. 1B). As we
dialyzed GST-SNAP-25 (10
8 M) into these
BoNT/A-transfected cells, we observed a decline in KDR
currents that paralleled the decline seen with GST-SNAP-25 dialyzed
into control cells over a similar time period of 12 min after membrane
rupture (Fig. 4C). This reached a maximum level of 84 ± 1% (n = 5, p < 0.05) of the
initial control cell value, which when compared with the initial value
of BoNT/A-transfected cells (123%), was a reduction of 39% (Fig.
4C). This percentage reduction is identical to that seen
with GST-SNAP-25 dialysis into control cells. Of note, after 12 min,
the KDR currents in the BoNT/A-transfected cells began to
recover as a result of BoNT/A action (Fig. 4C). The time
course of this recovery of KDR currents resulting from
BoNT/A cleavage of the dialyzed SNAP-25 is consistent with the
predicted enzymatic activity of BoNT/A, as reported by in
vitro proteolysis of recombinant SNAP-25 by BoNT/A (41). By 30 min, KDR activity completely recovered, reaching levels identical to those recorded immediately after initial membrane rupture
(Fig. 4C). This indicates complete cleavage of SNAP-25, rendering it incompetent to modulate KDR.
SNAP-25 Interacts with KV
1.1 and
KV
1.1 Subunits--
These functional data therefore
suggested the possibility that SNAP-25 could interact with
Kv1.1 channel proteins. To test this possibility, we
examined whether SNAP-25 is in a complex with the
-subunit of the
KV1.1 channel (Fig.
5A). To demonstrate the
general applicability of these findings to neurons and since these
proteins are less abundant in HIT cells, we performed
immunoprecipitation studies using rat brain LP1 synaptosomal fractions
(s-LP1) shown in lane 1 to be enriched in SNAP-25
and KV1.1 proteins (Fig. 5A). Of note,
lane 2 shows that a rabbit anti-SNAP-25 antibody generated against the full-length SNAP-25 (22) immunoprecipitated SNAP-25 from
the solubilized LP1 fraction and co-precipitated KV1.1
proteins. In control studies, an ~50-kDa protein was detected that is
likely an IgG heavy chain (lane 3) and which was also
observed in lane 2. Neither SNAP-25 nor KV1.1
proteins were precipitated by either the preimmune IgG (lane
3) or protein-G-Sepharose in the lysis buffer (lane
4).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
SNAP-25 interacts with KV1.1
proteins. A, co-precipitation of rat brain SNAP-25 and
KV1.1. Lane 1, solubilized LP1 fraction
(s-LP1) of rat brain synaptosomes shows clear bands for
KV1.1 and SNAP-25 proteins. Lane 2 shows that
the SNAP-25 antibody (SNAP-25) immunoprecipitated
(IP) SNAP-25 from the solubilized LP1 fraction and
co-precipitated KV1.1 channel proteins. Control studies
were performed in lanes 3 and 4. Lane 3, control
preimmune IgG precipitated an ~50-kDa protein (the IgG heavy chain).
Neither protein-G-Sepharose in lysis buffer (lane 4) or
preimmune IgG (lane 3) precipitated SNAP-25 or
KV1.1 channel proteins. B and C, the
KV1.1 ( ) and KV1.1/KV 1.1
( ) channels interact physically with SNAP-25 in oocytes.
B, top, digitized PhosphorImager scan of
SDS PAGE analysis of [35S]Met/Cys-labeled
KV1.1 SNAP-25 proteins co-immunoprecipitated by
KV1.1 antibody from homogenates of oocytes that were
uninjected (control), injected with KV1.1 (10 ng/oocyte; ) mRNA only, co-injected with SNAP-25 (1.25 ng/oocyte; +SNAP-25), or injected with SNAP-25 alone.
B, bottom, homogenates of each group of oocytes
were subjected to immunoprecipitation by SNAP-25 antibody. The protein
samples were analyzed on a 12% PAGE. The results shown are from one of
three independent experiments. C, top, reciprocal
co-immunoprecipitation using SNAP-25 antibody, carried out in oocytes
that were either uninjected (control), injected with
KV1.1 (10 ng/oocyte) together with KV 1.1 (30 ng/oocyte) without or with SNAP-25 (10 ng/oocyte) mRNAs ( and
 +SNAP-25, correspondingly), or injected with SNAP-25
alone (SNAP-25). Bottom, homogenates of each
group of oocytes were subjected to immunoprecipitation by
KV1.1 antibody. Oocytes used in this experiment had a low
level of endogenous proteins migrating as KV1.1 and
precipitated by the KV1.1 antibody, as we report previously
(42). The protein samples were analyzed on an 8% PAGE.
Arrows indicate the relevant proteins. The electrophoretic
mobilities of molecular mass standards (size in kDa) are shown along
the right (B) or left (C) of each
autoradiogram.
|
|
We showed earlier that Kv1.1 is in complex with
Kv
auxiliary subunits in brain synaptosomes and that
this channel exists in multimolecular complex consisting also of the
t-SNARE, syntaxin 1A (21). Also, we showed that the
Kv1.1/Kv
1.1 channel interacted physically
with syntaxin 1A expressed in Xenopus oocytes. Thus, syntaxin 1A could mediate the interaction between KV1.1 and
SNAP-25 in synaptosomes. To examine whether Kv1.1 could
interact directly with SNAP-25 without the mediation of other SNARE
proteins or neuronal presynaptic proteins, we employed the heterologous
expression system of Xenopus oocytes. We showed by SDS-PAGE
analysis of metabolically labeled proteins that SNAP-25 expressed in
oocytes co-immunoprecipitated using Kv1.1 antibody with
Kv 1.1 (
) co-expressed alone (
; Fig. 5B)
or together with Kv
1.1 (
; not shown). The specificity of the channel interaction with SNAP-25 was verified by reciprocal co-immunoprecipitation of Kv1.1 and Kv
1.1
with SNAP-25 using antibody against SNAP-25 (Fig. 5C). The
faint immunoreactive bands corresponding to Kv1.1 and
Kv
1.1 in oocytes injected with 
without SNAP-25
are probably the result of coprecipitation with the endogenous SNAP-25
homolog(s)2 (previously we
also detected endogenous syntaxin homolog(s) (21)) of the channel
proteins (which were better expressed in these oocytes than in oocytes
coexpressing also SNAP-25; compare the expression of Kv1.1
in Fig. 5C, bottom panel, lanes

+SNAP-25 and 
). As previously shown (42), the
Kv1.1 protein is expressed in oocytes mainly in the form of
a doublet of ~57 and ~54 kDa polypeptides that are
N-glycosylated and represent functional channels.
We then proceeded to determine the domain within the
Kv1.1/Kv
1.1 protein with which SNAP-25 would
directly interact. This study is particularly important since we had
detected a small amount of endogenous syntaxin homolog(s) in oocytes
(21), which raised the possibility that SNAP-25 binding to the
Kv1.1 could be mediated by the binding to the endogenous
syntaxin. We have measured the in vitro binding of
35S-labeled SNAP-25 synthesized in reticulocyte lysate to
the following bacterially expressed recombinant proteins: GST
C,
corresponding to amino acids 411-495, i.e. the whole-length
C terminus of Kv1.1; GST
T1A and GST
T1B, corresponding
to amino acids 1-71 (containing 30 amino acids that comprise T1A
domain) and 72-143 of the N terminus of Kv1.1,
respectively (both are involved in tetramerization of Kv
subunits (43
45), and the latter is involved also in Kv
subunit binding (46, 47); GST
c, corresponding to amino acids 75-397, a region in Kv
that is conserved among the
different Kv
isoforms and is involved in binding to
Kv1.1; and
full, corresponding to the whole length of
Kv
1.1 (amino acids 1-397). Fig.
6A shows that SNAP-25 bound to
full-length Kv
1.1 and to its C terminus, to the N
terminus, and preferentially to the T1A domain but not to the C
terminus of Kv1.1. Next we set out to test if there was a
causative relationship between the direct interaction of the channel
with SNAP-25 and the functional interaction that leads to inhibition of
the current. To this end we tried to acutely rescue the channel in HIT
cells overexpressing SNAP-25 from the functional effects of SNAP-25 by
dialysis of a peptide corresponding to a domain of the channel that is
involved in SNAP-25 binding. The N-terminal domain of
Kv
1.1 was chosen for the following considerations. The
oocyte results demonstrated that Kv1.1 alone can bind
SNAP-25, and the in vitro binding results pointed to its N
terminus. Also, the in vitro binding results showed that the
C-terminal domain of Kv
, a region that is conserved
among the different Kv
isoforms, does bind SNAP-25.
Because this domain binds the N-terminal domain of Kv1.1
(46, 47), we assumed that the impact of its possible physical
interaction with SNAP-25 could be transferred to the N terminus of
Kv1.1, conferring its functional effect. In any case,
whether it interacts directly with SNAP-25 or indirectly via
interaction with Kv
, excess soluble N-terminal
Kv1.1 is likely to interfere with the interaction of the
endogenous membrane-bound Kv1.1 protein with SNAP-25.
Indeed, dialysis of the recombinant
T1A or N termini (amino acids
1-168) but not the
T1B (data not shown), C- termini (amino acids
411-495), or GST resulted in the augmentation of the outward current
(28-35% over control levels), presumably preventing the functional
effect of SNAP-25 by disrupting its physical interaction with the
channel proteins (Fig. 6B). We further showed that neither
the N- nor C-terminal domains had any effect on KDR
currents of BoNT/A-transfected HIT cells (data not shown). Taken
together, these binding and functional data point to a link between the
functional effects of SNAP-25 on the Kv1.1 channel and its
physical interaction with this channel protein.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 6.
Interactions of specific domains of
KV1.1 and KV 1.1 with
SNAP-25. A, top, 200 pmol of GST fusion
proteins corresponding to the indicated cytosolic parts of
KV1.1 and KV 1.1 (see precise sequences under
"Results") immobilized on GSH-agarose beads were incubated with 5 µl of in vitro synthesized 35S-labeled SNAP-25
in a 1-ml reaction volume. After elution with glutathione, proteins
were separated on 12% gel and analyzed by PhosphorImager to detect the
co-precipitation of SNAP-25. A, bottom, Coomassie
Blue staining of the same gel shows each of the eluted GST fusion
proteins. Numbers refer to mobility of prestained molecular
weight standards. Each panel is a representative experiment
of three similar experiments. B, N-terminal domains of
KV 1.1 reverses the inhibitory effects of SNAP-25 on
KDR currents in HIT cells. Dialysis of recombinant T1A
(10 8 M, n = 5) or
KV1.11-168 (10 8 M,
n = 6) via the patch pipette enhanced the
KDR current in SNAP-25-transfected cells. In contrast,
dialysis of GST (10 8 M, n = 6) or the cytoplasmic C-terminus of KV1.1 (amino acids
411-495, KV1.1411-495, 10 8
M, n = 6) had no effect on the
KDR current in SNAP-25-transfected cells. Whole-cell
currents were evoked in response to +30 mV from a holding potential of
-70 mV just after cell membrane rupture (t = 0) and 6 min later (t = 6 min). Data are the mean ± S.E.
summarized in the bar graph (B, lower
panel). The asterisk indicates p < 0.05 versus t = 0. pF, picofarads.
|
|
 |
DISCUSSION |
Here we present the first evidence that SNAP-25 interacts with and
inhibits the KDR (subtype Kv1.1) channel.
Although the overexpressed SNAP-25 had a small effect in reducing the
cell surface expression of Kv1.1 (Fig. 2A),
dialysis of excess recombinant SNAP-25 protein acutely inhibited
KDR currents in both control and BoNT/A-transfected HIT
cells (Fig. 4), which supports a primary inhibitory role of SNAP-25 on
the Kv1.1 channel. More importantly, the experiments on
BoNT/A cleavage of endogenous SNAP-25 (Figs. 1-3) demonstrated the
specific actions of the endogenous SNAP-25 in inhibiting
KDR currents.
Our biophysical analysis showed that SNAP-25 inhibited KDR
activity in part by altering channel kinetics so that the channel assumes a reluctant state by slowing channel activation and enhancing channel slow (C-type) inactivation (Figs. 1-3). Biochemical analysis in Xenopus oocytes and in vitro binding studies
revealed that the Kv1.1 channel interacts physically with
SNAP-25 both via the membrane pore-forming Kv
and the
peripheral auxiliary Kv
subunits (Figs. 5 and
6A). Both the functional and the physical interactions
indicate that the cytosolic N-terminal fragment of Kv
,
particularly the
T1A domain, acutely reverses the inhibitory effects
of SNAP-25 on KDR currents (Fig. 6B). The
crystal structures of the Kv
subunit and the T1 assembly
domain of the N terminus of Kv
subunit (48, 49) reveals
that submembrane modulating complexes interact with the core domain of
a channel responsible for the activation and C-type inactivation gating
(50). Very recently it has been demonstrated that a cytosolic
C-terminal complex conveys inhibition of HCN pacemaker channel gating
(51). Cleavage of SNAP-25 by BoNT/A expression relieved inhibition of KDR by SNAP-25 by reversing the SNAP-25 effects on
KDR kinetics. This indicates endogenous SNAP-25 has a
clamping effect on KDR.
Even though SNAP-25 can interact with the Kv1.1 channel
directly, it is likely that the molecular complex also involves other proteins. In fact, we recently report direct interactions of syntaxin 1A with Kv1.1 channel enhancing its rapid inactivation
(21). In that report, we showed that in brain synaptosomes, the
Kv
1.1 and Kv
subunits exist in a
macromolecular complex also comprising syntaxin 1A, SNAP-25, and
synaptotagmin. Such an interaction between Kv1.1 and the
exocytotic SNARE complex proteins is analogous to those described for
the Ca2+ channels. For example, SNAP-25 inhibited P/Q-type
Ca2+ channels, and this inhibition could be overcome by the
formation of a SNARE complex of SNAP-25 with syntaxin 1A and
synaptotagmin I (52). Similar modulation of N- and L-type
Ca2+ channels by the molecular interactions of these SNARE
proteins was also reported (13, 15). Further studies are required to examine whether these SNARE proteins and/or their associated proteins could modulate KDR channels independently or in complex
with SNAP-25. Notably, we also report that the G protein 
subunits directly interact with the N terminus of Kv
1.1
and with Kv
1.1 to affect fast (N-type) inactivation
gating (27). It will be of interest to examine possible complex
functional and physical interactions between SNAP-25, syntaxin 1A, and
G protein 
subunits.
Delayed-rectifier K+ channels (KDR) are
important regulators of membrane excitability in neurons and
neuroendocrine cells. Because the other major t-SNARE, syntaxin, has
been shown to interact directly with and modulate other ion channels
such as Na+ (17, 18), Ca2+ (12, 13, 15, 16),
and Cl
(19, 20) channels, our findings now extend the
repertoire of known SNARE-channel interactions to a member of the
important voltage-activated K+ channel (KV)
family. Our study shows that BoNT/A-mediated inhibition of secretion is
likely due to both the inhibitory effects of SNAP-25 cleavage and also
from the release of SNAP-25 inhibition of the KDR channel
protein, which ultimately leads to an inhibition of the sustained phase
of Ca2+ influx. Wei et al. (53) show that the
BoNT/A cleavage product SNAP-25
C9 exhibited a novel distinct action
on reducing the replenishment of the readily releasable pool in the
neuroendocrine chromaffin cell, which also reduced the sustained phase
of exocytosis as measured by membrane capacitance. Taken together,
these studies suggest that SNAP-25 acts on multiple targets to
orchestrate the sequence of events to effect optimal exocytosis,
including modulation of the membrane potential as a mechanism to
provide the appropriate feedback between these events.
 |
ACKNOWLEDGEMENTS |
We thank Yong Song and Michael Wheeler for
technical advice.
 |
FOOTNOTES |
*
This work was supported by grants from the National
Institutes of Health (DK55160), the Juvenile Diabetes Foundation,
Canadian Diabetes Association, and the Canadian Institute for Health
Research (to H. G.), and also by grants from the Israel Science
Foundation (437/98) and USA-Israel Binational Foundation (1999396) (to
I. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
¶¶
To whom correspondence should be addressed: Rm. 7226, Medical Sciences Bldg., 1 King's College Circle, University of
Toronto, Toronto, Ontario M5S 1A8, Canada. Tel.: 416-978-1526; Fax:
416-978-8765; E-mail: herbert.gaisano@utoronto.ca.
Published, JBC Papers in Press, March 29, 2002, DOI 10.1074/jbc.M201034200
2
S. Tsuk, D. Chikvashvili, and I. Lotan,
unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
KV, voltage-dependent K+ channels;
KDR, delayed rectifier K+ channels;
SNAP-25, synaptosome-associated protein of 25 kDa;
t-SNARE, target-SNAP
receptor;
v-SNARE, vesicle-SNAP receptor;
GST, glutathione
S-transferase;
BoNT/A, botulinum neurotoxin A;
TEA, tetraethylammonium;
DTX-K, dendrotoxin-K;
GFP, green fluorescent
protein.
 |
REFERENCES |
| 1.
|
Rorsman, P.
(1997)
Diabetologia
40,
487-495[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Dukes, I. D.,
and Philipson, L. H.
(1996)
Diabetes
45,
845-853[Abstract]
|
| 3.
|
Chow, R. H.,
Klingauf, J.,
and Neher, E.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12765-12769[Abstract/Free Full Text]
|
| 4.
|
Renstrom, E.,
Eliasson, L.,
and Rorsman, P.
(1997)
J. Physiol. (Lond.)
502,
105-118[Abstract/Free Full Text]
|
| 5.
|
Voets, T.,
Neher, E.,
and Moser, T.
(1999)
Neuron
23,
607-615[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Bressler, R.,
and Johnson, D. G.
(1997)
Arch. Intern. Med.
157,
836-848[Abstract]
|
| 7.
|
Sudhof, T. C.
(1995)
Nature
375,
645-653[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Weber, T.,
Zemelman, B. V.,
McNew, J. A.,
Westermann, B.,
Gmachl, M.,
Parlati, F.,
Weis, W. I.,
and Scheller, R. H.
(1998)
Nature
395,
328-329[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Hayashi, T.,
McMahon, H.,
Yamasaki, S.,
Binz, T.,
Hata, Y.,
Sudhof, T. C.,
and Niemann, H.
(1994)
EMBO J.
13,
5051-5061[Medline]
[Order article via Infotrieve]
|
| 10.
|
Pellegrini, L. L.,
O'Connor, V.,
Lottspeich, F.,
and Betz, H.
(1995)
EMBO J.
14,
4705-4713[Medline]
[Order article via Infotrieve]
|
| 11.
|
Xu, T.,
Binz, T.,
Niemann, H.,
and Neher, E.
(1998)
Nat. Neurosci.
1,
192-200[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Sheng, Z.-H.,
Rettig, J.,
Cook, T.,
and Catterall, W. A.
(1996)
Nature
379,
451-454[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Wiser, O.,
Bennet, M. K.,
and Atlas, D.
(1996)
EMBO J.
15,
4100-4110[Medline]
[Order article via Infotrieve]
|
|